Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep 1;57(9):920.
doi: 10.3390/medicina57090920.

Proadrenomedullin in Sepsis and Septic Shock: A Role in the Emergency Department

Andrea Piccioni  1 , Angela Saviano  1 , Sara Cicchinelli  1 , Federico Valletta  1 , Michele Cosimo Santoro  1 , Tommaso de Cunzo  1 , Christian Zanza  1 , Yaroslava Longhitano  2 , Gianluca Tullo  1 , Pietro Tilli  1 , Marcello Candelli  1 , Marcello Covino  1 , Francesco Franceschi  1
Affiliations
Review

Proadrenomedullin in Sepsis and Septic Shock: A Role in the Emergency Department

Andrea Piccioni et al. Medicina (Kaunas). .

Abstract

Sepsis and septic shock represent a leading cause of mortality in the Emergency Department (ED) and in the Intensive Care Unit (ICU). For these life-threating conditions, different diagnostic and prognostic biomarkers have been studied. Proadrenomedullin (MR-proADM) is a biomarker that can predict organ damage and the risk of imminent death in patients with septic shock, as shown by a large amount of data in the literature. The aim of our narrative review is to evaluate the role of MR-proADM in the context of Emergency Medicine and to summarize the current knowledge of MR-proADM as a serum indicator that is useful in the Emergency Department (ED) to determine an early diagnosis and to predict the long-term mortality of patients with sepsis and septic shock. We performed an electronic literature review to investigate the role of MR-proADM in sepsis and septic shock in the context of ED. We searched papers on PubMed®, Cochrane®, UptoDate®, and Web of Science® that had been published in the last 10 years. Data extracted from this literature review are not conclusive, but they show that MR-proADM may be helpful as a prognostic biomarker to stratify the mortality risk in cases of sepsis and septic shock with different degrees of organ damage, guiding emergency physicians in the diagnosis and the succeeding therapeutic workup. Sepsis and septic shock are conditions of high complexity and have a high risk of mortality. In the ED, early diagnosis is crucial in order to provide an early treatment and to improve patient survival. Diagnosis and prognosis are often the result of a combination of several tests. In our opinion, testing for MR-proADM directly in the ED could contribute to improving the prognostic assessment of patients, facilitating the subsequent clinical management and intensive treatment by the emergency physicians, but more studies are needed to confirm these results.

Keywords: MR-proADM; emergency department; proadrenomedullin; procalcitonin; sepsis; septic shock.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Dugar S., Choudhary C., Duggal A. Sepsis and septic shock: Guideline-based management. Clevel. Clin. J. Med. 2020;87:53–64. doi: 10.3949/ccjm.87a.18143. - DOI - PubMed
    1. Spoto S., Fogolari M., De Florio L., Minieri M., Vicino G., Legramante J., Lia M.S., Terrinoni A., Caputo D., Constantino S., et al. Procalcitonin and MR-proAdrenomedullin combination in the etiological diagnosis and prognosis of sepsis and septic shock. Microb. Pathog. 2019;137:103763. doi: 10.1016/j.micpath.2019.103763. - DOI - PubMed
    1. Li Q., Wang B.S., Yang L., Peng C., Ma L.B., Chai C. Assessment of adrenomedullin and proadrenomedullin as predictors of mortality in septic patients: A systematic review and meta-analysis. Med. Intensiv. 2018;42:416–424. doi: 10.1016/j.medin.2017.10.013. - DOI - PubMed
    1. Fahmey S.S., Mostafa H., Elhafeez N.A., Hussain H. Diagnostic and prognostic value of proadrenomedullin in neonatal sepsis. Korean J. Pediatr. 2018;61:156–159. doi: 10.3345/kjp.2018.61.5.156. - DOI - PMC - PubMed
    1. Mierzchala-Pasierb M., Lipinska-Gediga M., Fleszar M.G., Lesnik P., Placzkowska S., Serek P., Wisniewski J., Gamian A., Krzystek-Korpacka M. Altered profiles of serum amino acids in patients with sepsis and septic shock—Preliminary findings. Arch. Biochem. Biophys. 2020;691:108508. doi: 10.1016/j.abb.2020.108508. - DOI - PubMed